MEI Pharma, Inc.
Combination therapies
Last updated:
Abstract:
Provided herein are methods of treating and sensitizing cancer comprising administering a glycolytic inhibitor and an oxidative phosphorylation inhibitor.
Status:
Grant
Type:
Utility
Filling date:
1 Feb 2016
Issue date:
20 Apr 2021